GHK-Cu
Reviewed
Short answer
A three-amino-acid copper complex with topical and laboratory research. That research does not validate injectable, whole-body, or longevity claims. No FDA-approved injectable GHK-Cu drug product.
The Peptide Field explains research. Its pages are not independently medically reviewed, and they do not diagnose, prescribe, or recommend treatment.
Read the study findingsAlso known as copper tripeptide-1 · glycyl-L-histidyl-L-lysine copper · GHK copper
Part of Healing and recovery peptides
Legal status Is GHK-Cu legal? See the status table
Study and product details
What it is
GHK-Cu is a copper complex of a three-amino-acid peptide. Cosmetic ingredients, topical study products, and compounded injections are different evidence categories.
Type of peptide: Copper-binding tripeptide complex. This describes what the substance is or how it works. It does not show that it is safe, effective, or approved.
What has been studied?
- Limited: Research is too small or incomplete, or does not directly answer this question.
- Unclear: There is not enough reliable detail about the product or research to judge.
Small formulation-specific human studies exist, but broad regenerative and anti-aging outcomes are not established.
Copper binding and cell-level signaling are biologically plausible but not equivalent to clinical benefit.
Human information is limited, and FDA identifies injectable immunogenicity and impurity concerns.
Formulation and route strongly affect what evidence can be transferred.
Products with the same ingredient can differ.
The ingredient name does not tell you everything about a product. Check its other ingredients, its form, how it enters the body, and the use and people covered by the research or approval.
None identified in the United States.
- No FDA-approved drug indication
Have a lab test report (COA) for a product sold under this name? Check what the report shows in 10 questions
Not sure if a product sold under this name is a prescription, compounded, or research-only vial? Sort it in 5 questions
What studies found
One small randomized topical study after laser resurfacing had 13 people who completed it. It found no significant between-group improvement in erythema, wrinkles, or objectively assessed skin quality, although questionnaire-reported satisfaction was higher in the GHK-Cu group. FDA says human data are limited and flags potential immunogenicity from aggregates and peptide-related impurities for injectable routes.
The evidence does not establish that injected GHK-Cu rejuvenates organs, repairs injury throughout the body, reverses aging, or produces the same effects as a studied topical formulation.
Which products do these findings apply to?
A topical product and an injectable product are not the same evidence question. Topical formulations, compounded non-injectable products, and injectable products are different evidence questions. FDA separately flags injectable GHK-Cu risks.
GHK-Cu side effects and safety: what FDA has said
This page has no trial or drug-label side-effect table for GHK-Cu. FDA keeps a page of bulk substances that may be risky when a pharmacy mixes (compounds) them. Here is what that page says about GHK-Cu, in plain words.
FDA's page does not name specific side effects for GHK-Cu.
FDA's entry covers injectable GHK-Cu only. It does not cover creams or other products put on the skin.
- FDA says there are limited data in people to judge the safety of injected GHK-Cu.
- The body's immune system may react against injected GHK-Cu.
- The peptide may clump together, which adds to that risk.
- Making it may leave unwanted peptide by-products in the product.
These points come from FDA's review of compounded drugs. They are not a full list of side effects. Having no reports does not mean a product is safe.
Read FDA's exact words
GHK-Cu (for injectable routes of administration): “Compounded injectable drugs containing GHK-Cu may pose risk for immunogenicity due to the potential for aggregation and peptide-related impurities. There are limited data in humans to inform safety-related considerations.”
Source: FDA, Certain bulk drug substances for use in compounding that may present significant safety risks , page dated .
Compare side-effect data across peptides
Report a side effect
You can report a suspected side effect to the FDA at 1-800-FDA-1088 or through FDA MedWatch . If a reaction feels serious, get medical care first.
FDA page checked .
Fact checks
3 statements checked. Read what the results mean.
“GHK-Cu has been studied in people.”
Yes, but the cited topical trial had 13 completers, found no significant objective improvement in erythema, wrinkles, or skin quality, and reported higher patient satisfaction. It does not establish broader outcomes or other routes.
- What this answer is based on
- Health results from a study with randomly assigned groups
- Limits of this answer
- A specific topical copper-tripeptide formulation after CO2 laser resurfacing.
Sources for this fact check (1)
“Topical GHK-Cu evidence proves injectable GHK-Cu works systemically.”
Route, formulation, exposure, product quality, and endpoint differ. Evidence cannot be transferred by ingredient name alone.
- What this answer is based on
- Official record or product label
- Limits of this answer
- Topical study formulations versus compounded injectable products.
Sources for this fact check (1)
“Injectable GHK-Cu is proven safe.”
FDA identifies limited human data and potential immunogenicity related to aggregation and peptide impurities.
- What this answer is based on
- Official record or product label
- Limits of this answer
- Compounded injectable GHK-Cu.
Sources for this fact check (1)
Questions people ask about GHK-Cu
FDA's page on risky compounding substances says this about GHK-Cu. It does not name specific side effects for GHK-Cu. FDA's entry covers injectable GHK-Cu only. It does not cover creams or other products put on the skin. FDA says there are limited data in people to judge the safety of injected GHK-Cu. The body's immune system may react against injected GHK-Cu. The peptide may clump together, which adds to that risk. Making it may leave unwanted peptide by-products in the product. These points come from FDA's review of compounded drugs. They are not a full list of side effects.
Risks and safety limits
Route and formulation are part of the claim. This guide does not provide injectable-use, compounding, cosmetic-treatment, or wound-care instructions.
This editorial review did not determine sport eligibility. Athletes must check the current prohibited list, Global DRO, and their governing body.
Reviewed .Check the rules for athletes ↗Terms used in the studies
- peptide
- a short chain of amino acids
- randomized
- assigned to study groups by chance
- route
- how the product enters the body
- formulation
- the ingredients and physical form of the finished product
- compounded
- made for one patient by a pharmacy, or in batches by a permitted outsourcing facility; a compounded drug is not FDA-approved
- outcome
- what the study measured
- amino acid
- a small building block that makes peptides and proteins
- indication
- the approved or studied use and patient group
Read the sources
Show 3 sources
Review history
Initial brief separates topical formulation studies from injectable-product claims.
Not independently medically reviewed. This page is not a dosing, sourcing, or treatment guide.
Report a factual error